Starpharma: Commencement of Phase 1 Trial for AZD0466 Utilising DEP® Delivery Technology
AstraZeneca has commenced its first-in-human/phase 1 clinical trial for AZD0466 in the US in a range of cancers AZD0466 utilises…
Pharmaceuticals, Biotechnology and Life Sciences
AstraZeneca has commenced its first-in-human/phase 1 clinical trial for AZD0466 in the US in a range of cancers AZD0466 utilises…
BEIJING–(BUSINESS WIRE)–Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that…
Worldwide will serve as CRO for the Company’s Clinical Programs Evaluating Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type…
DUBLIN–(BUSINESS WIRE)–The “Latin America 3D Cell Culture Market 2019-2027” report has been added to ResearchAndMarkets.com’s offering. The Latin America market…
BRIDGEWATER, N.J.–(BUSINESS WIRE)–Amneal Pharmaceuticals, Inc. (NYSE: AMRX) today announced that members of management will present at the 38th Annual J.P.…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on developing immune modulators and…
SEATTLE–(BUSINESS WIRE)–#CROmarket–According to Coherent Market Insights, the U.S. contract research organization (CROs) market is estimated to be valued at US$…
~We are the company aiming to achieve productive aging worldwide by delivering science of wellness based on research evidence~ TOKYO–(BUSINESS…
ISS Confirms OncoSec Presented a ‘Compelling Case’ for the Necessity of the CGP/Sirtex Transaction ISS Highlights the Benefits of the…
ALAMEDA, Calif.–(BUSINESS WIRE)–AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company focused on developing therapeutics for human aging and…